Anuh Pharma Investor Relations Material
Latest events
Q4 24/25
23 May, 2025
Q3 24/25
7 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Anuh Pharma Limited
Access all reports
Anuh Pharma Limited is a pharmaceutical company primarily engaged in the manufacturing and export of active pharmaceutical ingredients (APIs). The company produces APIs for a range of therapeutic segments, including antibiotics, antihistamines, and antituberculosis agents. Its operations include chemical synthesis, quality control, and regulatory compliance to meet the standards of domestic and international markets. Anuh Pharma Limited serves pharmaceutical manufacturers globally and may also offer contract manufacturing services. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Key slides for Anuh Pharma Limited
Q2 24/25
Anuh Pharma Limited
Q4 24/25
Anuh Pharma Limited
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
506260
Country
🇮🇳 India